Munafa Stock Market Course + Intraday & FNO calls 
Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Arbutus Biopharma (ABUS)
Technical Analysis Report for USA stock ABUS Arbutus Biopharma. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma then click here. or read Experts views on Arbutus Biopharma or Forecast & share price targets of Arbutus Biopharma
Arbutus Biopharma Opened at 3.77 and Closed at: 3.85, which is 4.68% of previous session's close. It moved within a range of 3.67 and 3.97
The session was a Bullish session with an average volume of 1922890, which is 16.45% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 3.76 and resistance for tomorrow is 4.06
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.69, 3.53 resistance for tomorrow's hourly charts is 3.99, 4.13
10 Day SMA for Arbutus Biopharma (ABUS) is 4.05 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Arbutus Biopharma (ABUS) is 4.22 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Arbutus Biopharma (ABUS) is 4.45 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 4.45 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Arbutus Biopharma is 3.94 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Arbutus Biopharma is at 4.22 and 200 DMA is at 3.94, while 50 DMA and 100 DMA are at 4.45 and 4.45 respectively
Arbutus Biopharma (ABUS) moving average of 20 SMA is at 4.22 and 20 EMA is at 4.18
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 3.85 | 4.22 | 4.18 |
| 05 Thu Feb | 3.67 | 4.26 | 4.22 |
| 04 Wed Feb | 3.88 | 4.33 | 4.28 |
| 03 Tue Feb | 4.11 | 4.37 | 4.32 |
| 02 Mon Feb | 4.39 | 4.4 | 4.34 |
| 30 Fri Jan | 4.13 | 4.42 | 4.34 |
Arbutus Biopharma (ABUS) moving average of 50 SMA is at 4.45 and 50 EMA is at 4.35
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 3.85 | 4.45 | 4.35 |
| 05 Thu Feb | 3.67 | 4.45 | 4.37 |
| 04 Wed Feb | 3.88 | 4.47 | 4.4 |
| 03 Tue Feb | 4.11 | 4.47 | 4.42 |
| 02 Mon Feb | 4.39 | 4.48 | 4.43 |
| 30 Fri Jan | 4.13 | 4.48 | 4.43 |
Arbutus Biopharma (ABUS) moving average of 100 SMA is at 4.45 and 100 EMA is at 4.33
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 3.85 | 4.45 | 4.33 |
| 05 Thu Feb | 3.67 | 4.45 | 4.34 |
| 04 Wed Feb | 3.88 | 4.46 | 4.35 |
| 03 Tue Feb | 4.11 | 4.47 | 4.36 |
| 02 Mon Feb | 4.39 | 4.48 | 4.37 |
| 30 Fri Jan | 4.13 | 4.48 | 4.37 |
Arbutus Biopharma (ABUS) moving average of 200 SMA is at 3.94 and 200 EMA is at 4.2
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 3.85 | 3.94 | 4.2 |
| 05 Thu Feb | 3.67 | 3.94 | 4.2 |
| 04 Wed Feb | 3.88 | 3.94 | 4.21 |
| 03 Tue Feb | 4.11 | 3.93 | 4.21 |
| 02 Mon Feb | 4.39 | 3.93 | 4.21 |
| 30 Fri Jan | 4.13 | 3.92 | 4.21 |
Resmed Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Resmed Inc, about 24.26% more returns!
Novartis Ag has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Novartis Ag, about 27.18% more returns!
Msa Safety has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Msa Safety, about 27.68% more returns!
Mednax Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Mednax Inc, about 10.18% more returns!
Cigna Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Cigna Corporation, about 21.37% more returns!
Tg Therapeutics has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Tg Therapeutics, about 18.07% more returns!
Arbutus Biopharma has performed better than Staar Surgical in short term. Holding Arbutus Biopharma could be a better choice for now!
Rocket Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Rocket Pharmaceuticals, about 1.12% more returns!
Pacira Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 5.92% more returns!
Omeros Corporation has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Omeros Corporation, about 6.58% more returns!
Livanova Plc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Livanova Plc, about 20.01% more returns!
Arbutus Biopharma has performed better than Kura Oncology in short term. Holding Arbutus Biopharma could be a better choice for now!
Genesis Healthcare has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Genesis Healthcare, about 6.62% more returns!
National Vision has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in National Vision, about 26.46% more returns!
Dermira Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Dermira Inc, about 31.53% more returns!
Caredx Inc has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Caredx Inc, about 30.33% more returns!
Aurinia Pharmaceuticals has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Aurinia Pharmaceuticals, about 11.98% more returns!
Acadia Healthcare has performed better than Arbutus Biopharma in short term. You could have earned much better returns by investing in Acadia Healthcare, about 15.49% more returns!
Arbutus Biopharma Technical analysis of indicators
Price action analysis of Arbutus Biopharma (ABUS) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.11 and Arbutus Biopharma ABUS stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma ABUS stock. Volume based technical analysis of Arbutus Biopharma ABUS stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock ABUS Arbutus Biopharma These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And ABUS Experts View which covers a lot of information including buying and selling signals
ABUS future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Arbutus Biopharma or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Arbutus Biopharma (ABUS) Technical (Analysis) Reports Arbutus Biopharma ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
